QR-koodi

Study protocol for developing a patient-reported outcome measure for infection screening in hematological patients with secondary immunodeficiency

Abstract Background Patients with chronic lymphocytic leukemia (CLL) or multiple myeloma (MM) frequently develop secondary immunodeficiencies (SID), on the basis of both their respective disease, as well as immunosuppressive therapies, leading to increased infection risks and impaired health-related...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Jens Lehmann, Jan-Paul Bohn, Claudia Seidl, Samuel M. Vorbach, Wolfgang Willenbacher, Bernhard Holzner, Markus Schuler
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMC 2025-10-01
Sarja:BMC Cancer
Aiheet:
Linkit:https://doi.org/10.1186/s12885-025-14996-y
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!